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Systematic Review Protocol: The effects of glucocorticoids on selected
hemodynamic and biochemical parameters in dogs and cats
Abstract
Objective: The objective of this scoping review is to define the scope of literature pertaining to the effects of
glucocorticoids in dogs or cats on selected parameters that may affect cardiac function or fluid balance (blood
glucose, blood pressure, sodium and potassium levels, echocardiographic or invasive hemodynamic indices, or
indicators of volume status). It is our intention that after evaluating the available literature, we will then make a
determination of the potential to conduct a systematic review and meta-analysis of the relevant literature for
specific interventions.
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Systematic	Review	Protocol:	The	effects	of	glucocorticoids	on	selected	hemodynamic	and	biochemical	parameters	in	
dogs	and	cats	
Jessica	Ward,	Allison	Masters,	and	Annette	O’Connor	
	
Objective:	The	objective	of	this	scoping	review	is	to	define	the	scope	of	literature	pertaining	to	the	effects	of	
glucocorticoids	in	dogs	or	cats	on	selected	parameters	that	may	affect	cardiac	function	or	fluid	balance	(blood	glucose,	
blood	pressure,	sodium	and	potassium	levels,	echocardiographic	or	invasive	hemodynamic	indices,	or	indicators	of	
volume	status).	It	is	our	intention	that	after	evaluating	the	available	literature,	we	will	then	make	a	determination	of	the	
potential	to	conduct	a	systematic	review	and	meta-analysis	of	the	relevant	literature	for	specific	interventions.			
	
Eligibility	criteria:	
• Population:	dogs	or	cats	(any	age,	any	sex,	any	source	[colony	or	client-owned],	healthy	or	diseased)	
• Intervention:	glucocorticoid	given	systemically	(PO,	IV,	IM,	or	SQ;	NOT	topical,	inhaled,	or	other	routes)	OR	
hyperadrenocorticism	diagnosed	
• Comparator:	parallel	control	group	OR	single	arm	pre/post	
• Outcome	variables:		
o Mean	change	from	baseline	in	blood	glucose	
o Mean	change	from	baseline	in	blood	pressure	
o Mean	change	from	baseline	in	blood	sodium	or	potassium		
o Mean	change	from	baseline	in	echocardiographic	or	invasive	hemodynamic	measurements	of	cardiac	
structure	or	function	
o Mean	change	from	baseline	in	indicators	of	volume	status	(blood	volume,	plasma	volume,	or	body	
weight)	
• Study:	all	study	designs	accepted	
o All	years	and	languages	eligible		
Information	sources:	
• MEDLINE	–	no	year	restrictions		
• CABI	–	no	year	restrictions	
• Conference	proceedings:	ACVIM	Forum,	ECVIM	Convention,	AVMA	Convention,	AAHA,	AAVPT	Symposium,	AAFP	
Convention	–	past	3	years	only	
• Citations	extracted	to	EndNote	for	further	characterization	
Search	strategy:	
• POPULATION:	(dog	or	canine	or	cat	or	feline)	
o Plurals	not	required	(no	difference	in	search	results	if	plurals	used)		
• AND	EXPOSURE:	any	of	the	following	
o General:	(glucocorticoid	or	glucocorticoids	or	gluco-corticoid	or	gluco-corticoids	or	steroid	or	steroids	or	
corticosteroid	or	corticosteroids)	
§ Hyphens	are	needed	for	“glucocorticoid”	but	not	for	“corticosteroid”	
§ Plurals	are	needed	for	all	
o Specific	glucocorticoids:	(prednisone	or	prednisolone	or	methylprednisolone	or	hydrocortisone	or	
cortisol	or	cortisone	or	corticosterone	or	betamethasone	or	dexamethasone	or	triamcinolone	or	
fludrocortisone	or	budesonide	or	flumethasone	or	isoflupredone)	
§ Specific	trade	names	are	not	needed	(no	difference	in	search	from	generic	names	only)	
§ Plurals	are	not	needed	
o Endogenous	hypercortisolemia:	(hyperadrenocorticism	or	hypercortisolism	or	hypercortisolemia	or	
hypercortisolaemia	or	cushings	or	cushing’s	or	hyper-adrenocorticism	or	hyper-cortisolism	or	hyper-
cortisolemia	or	hyper-cortisolaemia)	
§ Hyphens	are	needed		
FINAL	SEARCH	PROTOCOL:	
CABI:		
	
MEDLINE:		
	
	
SCREENING	PROTOCOL	
Level	1:	Title/Abstract	Relevance	Screening	(2	independent	reviewers,	JW	+	AM)	
Screening	questions:	
• Is	this	primary	research?	
o Yes	à	go	forward	
o No	à	exclude	
o Can’t	tell	à	go	forward	
o Can’t	tell	à	exclude	
o Is	this	a	Proceedings	>5yrs	old	à	exclude	automatically	
• Are	the	study	subjects	dogs	or	cats?	
o Yes	à	go	forward	
o No	à	exclude	
o Can’t	tell	à	go	forward	
o Can’t	tell	à	exclude	
• 	Did	study	subjects	have	a	glucocorticoid	administered	OR	hyperadrenocorticism	diagnosed?	
o Highlight	relevant	words	used	in	the	search	for	easy	identification:	
§ Corticosteroid	or	corticosteroids	or	steroid	or	steroids	or	glucocorticoid	or	gluco-corticoid	or	
glucocorticoids	or	gluco-corticoids	or	prednisone	or	prednisolone	or	methylprednisolone	or	
hydrocortisone	or	betamethasone	or	dexamethasone	or	triamcinolone	or	fludrocortisone	or	
budesonide	or	flumethasone	or	isoflupredone	
§ Hyperadrenocorticism	or	hypercortisolism	or	hypercortisolemia	or	hypercortisolaemia	or	
cushings	or	cushing's	or	hyper-adrenocorticism	or	hyper-cortisolism	or	hyper-cortisolemia	or	
hyper-cortisolaemia	
o Yes	à	go	forward	
o No	à	exclude	
o Can’t	tell	à	go	forward	
o Can’t	tell	à	exclude	
	
Level	2:	Full	Text	Relevance	Screening	and	Initial	Extraction	(2	independent	reviewers,	JW	+	AM)	
Level	2	screening	questions	
• Does	this	study	still	reach	relevance	based	on	level	1?	(Should	this	have	been	excluded	at	level	1?)	
o Yes	à	go	forward	
o No	à	exclude	
• Was	glucocorticoid	administered	systemically	(PO,	IV,	IM,	or	SQ	–	i.e.	not	topically/inhaled)?	
o Yes	à	go	forward	
o No	à	exclude	
• Does	the	study	include	some	type	control/comparison	group?		
o Yes	à	go	forward	
o No	à	exclude	
• 	Does	the	study	report	results	for	at	least	one	outcome	variable	of	interest?	
o Highlight	relevant	words	for	easy	identification:	
§ Glucose	OR	glycose	OR	glycemic	OR	glycaemic	OR	hyperglycemia	OR	hyperglycaemia	OR	sugar	
OR	glucosuria	OR	glycosuria	OR	glucosuric	OR	glycosuric	OR	diabetogenic	OR		diabetes	OR	
diabetic	OR	insulin	OR	fructosamine	
§ Pressure	OR	hypertension	OR	volume	OR	fluid	OR	water	OR	edema	OR	diuretic	OR	diuresis	OR	
blood	OR	plasma	PR	intravascular	OR	extracellular	
§ Heart	OR	cardiac	OR	failure	OR	echocardiography	OR	echocardiogram	OR	echocardiograph	OR	
hemodynamic	OR	hemodynamics	OR	ventricular	OR	ventricle	OR	hypertrophy	OR	hypertrophic	
OR	myocardium	OR	myocardial	
§ Sodium	OR	potassium	OR	mineralocorticoid	OR	mineralo-corticoid	
o Yes	à	go	forward	
o No	à	exclude	
Level	2	data	extraction	questions	
• What	species	was	studied?	(check	all	that	apply)	
o Dogs	
o Cats	
• What	was	the	intervention?	(check	all	that	apply)	
o Glucocorticoid	administered	
o Hyperadrenocorticism	
• What	was	the	route	of	GC	administration?	(check	all	that	apply)	
o PO	
o IV	
o IM	
o SQ	
• What	is	the	control/comparison	group	(check	all	that	apply):	
o Study	animals	at	baseline	before	glucocorticoid/hyperadrenocorticism	
o Study	animals	after	washout	post-glucocorticoid/hyperadrenocorticism	
o Parallel	group	of	untreated/unaffected	dogs	
o Parallel	group	of	dogs	treated	with	medication	other	than	GC	
o Other	type	of	comparison	group	
• Which	outcome	measures	were	investigated?	(check	all	that	apply	OR	add	new)	
o Blood	glucose	metabolism	
o Blood	pressure	
o Na/K	(mineralocorticoid	effect)	
o Echocardiography	
o Radiographic/CT/MRI	heart	size	
o Fluid	balance:	plasma	volume,	total	body	water,	extracellular	water	
o Invasive	hemodynamics	(cardiac	output,	stroke	volume,	etc)	
	
	
	 	
Level	3:	Full	Text	Data	Extraction	(worksheet)	
Study	subjects	 ⃝		Domestic	dogs						⃝		Domestic	cats		
Intervention	 ⃝		GC									⃝		HAC			(this	choice	triggers	which	shaded	boxes	below	are	shown)	
Route	of	GC	 ⃝		PO									⃝		IV											⃝		IM									⃝	SQ	
Comparison	group	 ⃝		Control	group	(untreated)						
⃝		Control	group	(treated	with	medication	other	than	GC)			
⃝		Treatment	animals	before/after	GC					
⃝		Other	comparison	group	
	
	
Comparison	group	 ⃝		Control	group													⃝		HAC	before/after	treatment	of	HAC																					⃝		Other		
	
	
Year	published	 	
Country	where	work	
performed	
	
Study	setting	 ⃝	Veterinary	school							⃝	Specialty	referral	hospital								⃝	General	practice					⃝	Research	lab	(not	vet	school)	
	Setting	not	discussed	or	unclear																																																																														⃝	Other				
	 	
Source	of	animals	 ⃝	Client-owned												⃝Experimental/Research	colony									⃝Shelter															⃝Other		
Data	collection	 ⃝	Prospective												⃝Retrospective															⃝Other/Unclear		
Total	#	of	study	groups	
(including	control)	
①				②				③			④			⑤			⑥	
Assign	labels	to	all	
treatment	groups	
indicated	above	
①		
	
②		
	
③		
	
(Can	add	more	if	needed	based	on	#	of	treatment	groups)	
	
(These	choices	then	populate	the	columns	in	“subject	data”	and	“GC	data”	or	“HAC	data”	below)	
Control	(untreated)	
	
	
Crossover	design?	 ⃝	Yes																⃝No		
If	yes:	
Washout	period	between	groups	(d):		____________________	
Total	#	of	study	subjects:	______________________	
#	of	treatment	arms	in	crossover:	____________________	
Other	details	of	crossover:		
	
	
Allocation	of	treatment	
groups	
⃝	Randomized	to	treatment	group							⃝	Allocated	to	treatment	group	but	not	random				
⃝	Approach	to	allocation	not	clear								⃝	N/A	(only	1	treatment	group)	
	⃝	N/A	(retrospective	study)	
Subject	data:	record	for	
each	study	group	
①	Control	(untreated)	 ②	
	
③		
	
Number	of	subjects	 	 	 	
Health	status		 	 	 	
Age	at	enrollment	(yr)		
(mean/med,	SD/range)	
	 	 	
Sex		 Female:	(				)		#	altered:		(					)	
Male:		(				)			#	altered:		(					)	
Female:	(				)		#	altered:		(				)	
Male:		(				)			#	altered:		(				)	
Female:	(				)		#	altered:		(				)	
Male:		(				)			#	altered:		(					)	
Body	weight	(kg)	
(mean/med,	SD/range)	
	 	 	
Breed		 	
	
	
	 	
GC	data:	record	for	
each	study	group	
①		
	
②	
	
③	
Name	of	GC/other	drug	 	 	 	
Route		 	 	 	
Initial	dose	(mg/kg)	 	 	 	
Initial	frequency	(qXhr)	 	 	 	
Duration	of	GC	at	initial	
dose	
	 	 	
Taper	of	GC?	(y/n)	 	 	 	
Description	of	taper	 	 	 	
	
	
Total	duration	of	GC	(d)	 	 	 	
Other	drug(s)	given	to	
study	group	
	
	
	 	 	
HAC	data:	record	for	
each	study	group	
①		 ②		
	
③		
Etiology	of	HAC	 ⃝	Spontaneous										
⃝	Drug-induced									
⃝	N/A	
⃝	Spontaneous										
⃝	Drug-induced									
⃝	N/A	
⃝	Spontaneous										
⃝	Drug-induced									
⃝	N/A	
How	was	HAC	
diagnosed?	
⃝	ACTH	stim										
⃝	LDDS									
⃝	Other			
	
	
⃝	ACTH	stim										
⃝	LDDS									
⃝	Other			
	
	
⃝	ACTH	stim										
⃝	LDDS									
⃝	Other			
	
	
Duration	of	HAC	prior	
to	study	
	 	 	
HAC	controlled	
medically	at	d0	of	
study?	
⃝	No													⃝	Yes									
⃝	N/A											⃝	Not	recorded	
How	HAC	treated/controlled:		
	
	
⃝	No													⃝	Yes									
⃝	N/A											⃝	Not	recorded	
How	HAC	treated/controlled:		
	
	
⃝	No													⃝	Yes									
⃝	N/A											⃝	Not	recorded	
How	HAC	treated/controlled:		
	
	
HAC	treated	during	
study?	
⃝	No													⃝	Yes							⃝	N/A					
Treatment:		
	
	
⃝	No													⃝	Yes						⃝	N/A				
Treatment:		
	
	
⃝	No													⃝	Yes							⃝	N/A	
Treatment:		
	
	
Outcome	measures	
assessed;	description	of	
outcome	measure	
⃝	Blood	glucose	metabolism	
	
⃝		Blood	pressure		
	
⃝		Electrolytes		
	
⃝		Echocardiography		
	
⃝		Heart	size	on	CXR,	CT,	MRI		
	
⃝		Fluid	balance,	plasma	volume	total	body	water			
	
⃝		Invasive	hemodynamics	(CO,	SV,	etc)		
	
⃝		Other	(add	if	needed):					
	
(These	choices	then	populate	the	columns	in	“Outcome	measure	data”	below)	
	
	
	
	
	
	
	
	
Outcome	measure	
data:	record	for	each	
outcome	measure	
assessed	
(A)		 (B)	
	
©		
Treatment	groups	in	
which	outcome	
measure	was	assessed	
(y/n)	
①	
②	
③	
①	
②	
③	
①	
②	
③	
Time	points	(d0-dX)	
outcome	measure	was	
assessed	for	each	
treatment	group	
Group	①:	_____________	
Group	②:	_____________	
Group	③:	_____________	
Group	①:	_____________	
Group	②:	_____________	
Group	③:	_____________	
Group	①:	_____________	
Group	②:	_____________	
Group	③:	_____________		
Timing	of	outcome	
measure	assessment	
(time	during	day)	
⃝	Fasted	(y.n)	
⃝	#	hours	post-tx:	____________	
⃝	Other	timing:	________	
⃝	Not	specified	
	
⃝	Fasted	(y/n)	
⃝	#	hours	post-tx:	____________	
⃝	Other	timing:	________	
⃝	Not	specified	
	
⃝	Fasted	(y/n)	
⃝	#	hours	post-tx:	____________	
⃝	Other	timing:	________	
⃝	Not	specified	
	
Was	outcome	
assessment	blinded?	
⃝	No													⃝	Yes									
	⃝	Not	recorded	
	
⃝	No													⃝	Yes									
	⃝	Not	recorded	
	
⃝	No													⃝	Yes									
	⃝	Not	recorded	
	
Other	notes	 	
	
	
	
